Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-amino-2-ethyl-, also known as 4-amino-2-ethylbenzoic acid, is an organic compound with the chemical formula C9H11NO2. It is a white crystalline solid that is soluble in water and has a molecular weight of 165.19 g/mol. Benzoic acid, 4-amino-2-ethyl- is a derivative of benzoic acid, featuring an amino group at the 4-position and an ethyl group at the 2-position. It is used in the synthesis of various pharmaceuticals, dyes, and other organic compounds. Due to its unique structure, it exhibits properties such as acidity, reactivity with electrophiles, and the ability to form salts with bases.

2486-74-0

Post Buying Request

2486-74-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2486-74-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2486-74-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,8 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2486-74:
(6*2)+(5*4)+(4*8)+(3*6)+(2*7)+(1*4)=100
100 % 10 = 0
So 2486-74-0 is a valid CAS Registry Number.

2486-74-0Downstream Products

2486-74-0Relevant academic research and scientific papers

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS

-

Page/Page column 98, (2020/07/14)

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein formula (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS

-

Page/Page column 44; 55, (2020/07/14)

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein NA (I) and pharmaceutically acceptable salts thereof.5 Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

-

Page/Page column 88; 99, (2020/07/14)

The invention provides novel imidazopyrazine derivatives having general formula (I), wherein R1 to R11 are as described herein, and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

NOVEL IMIDAZOPYRAZINE DERIVATIVES

-

Page/Page column 68, (2020/07/14)

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

-

Page/Page column 49-50, (2020/07/14)

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R14 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2486-74-0